Fate Therapeutics (FATE) Revenue (2012 - 2026)
Fate Therapeutics (FATE) reported Revenue of $2.08 million for Q2 2026, up 9.2% from $1.91 million a year earlier and up 60.3% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Revenue (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Fate Therapeutics' Revenue came in at $6.49 million, down 23.4% year-over-year; for FY2025, it was $6.65 million, down 51.2% from FY2024.
- Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -26.7% (FY2020 to FY2025).
- By year, Revenue came in at $13.63 million in FY2024 (-78.5%), $63.53 million in FY2023 (-34.0%), $96.3 million in FY2022 (+72.4%) and $55.85 million in FY2021 (+77.7%).
- The Q2 2026 figure ranks as the highest quarterly Revenue since Q3 2024.
- Year over year, Revenue gained in three of the last eight quarters, with an average decline of 12.4%.
- The high point for year-over-year Revenue in five years was Q2 2024 (growth of 625.8%); the low point was Q1 2024 (a decline of 96.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.3 million (Q1 2026), $1.37 million (Q4 2025) and $1.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Fate Therapeutics | 277.73 Mn | 277.73 Mn | - | 2.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 6.77 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 933,000.00 |
| Mar 31, 2023 | 58.98 Mn |
| Dec 31, 2022 | 44.36 Mn |
| Sep 30, 2022 | 14.98 Mn |
| Jun 30, 2022 | 18.55 Mn |
| Mar 31, 2022 | 18.41 Mn |
| Dec 31, 2021 | 17.07 Mn |
| Sep 30, 2021 | 14.23 Mn |
API Access
Fate Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();